Howard Silberman

3.1k total citations
62 papers, 2.4k citations indexed

About

Howard Silberman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Howard Silberman has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Howard Silberman's work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Howard Silberman is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Howard Silberman collaborates with scholars based in United States and Switzerland. Howard Silberman's co-authors include Susan Groshen, Lawrence Leichman, Cynthia G. Leichman, Joaquina Baranda, Loren Laine, Kathleen D. Danenberg, Melvin J. Silverstein, Peter F. Crookes, Heinz-Josef Lenz and P. V. Danenberg and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Howard Silberman

62 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Silberman United States 24 1.0k 852 759 565 538 62 2.4k
F Crucitti Italy 25 868 0.9× 590 0.7× 1.1k 1.4× 290 0.5× 322 0.6× 103 2.1k
Jan‐Sing Hsieh Taiwan 25 912 0.9× 697 0.8× 740 1.0× 375 0.7× 351 0.7× 79 2.0k
Tomoo Tajima Japan 23 1.2k 1.1× 557 0.7× 584 0.8× 416 0.7× 266 0.5× 153 2.2k
Carmine Pinto Italy 30 2.3k 2.3× 1.5k 1.7× 1.2k 1.6× 456 0.8× 360 0.7× 263 3.7k
Jyrki Mäkelä Finland 36 2.5k 2.4× 826 1.0× 2.4k 3.2× 370 0.7× 622 1.2× 130 4.5k
Narihide Goseki Japan 17 1.0k 1.0× 792 0.9× 1.0k 1.4× 282 0.5× 108 0.2× 80 2.6k
Şuayib Yalçın Türkiye 24 1.1k 1.1× 780 0.9× 470 0.6× 332 0.6× 205 0.4× 173 2.1k
Takashi Matsumata Japan 39 1.4k 1.4× 1.0k 1.2× 2.2k 2.9× 715 1.3× 388 0.7× 192 5.2k
Pierre H. Chapuis Australia 36 4.1k 4.0× 1.2k 1.4× 2.7k 3.5× 332 0.6× 989 1.8× 181 5.4k
Jy‐Ming Chiang Taiwan 31 2.2k 2.1× 565 0.7× 1.6k 2.1× 308 0.5× 522 1.0× 117 3.3k

Countries citing papers authored by Howard Silberman

Since Specialization
Citations

This map shows the geographic impact of Howard Silberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Silberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Silberman more than expected).

Fields of papers citing papers by Howard Silberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Silberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Silberman. The network helps show where Howard Silberman may publish in the future.

Co-authorship network of co-authors of Howard Silberman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Silberman. A scholar is included among the top collaborators of Howard Silberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Silberman. Howard Silberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macdonald, Heather, Melvin J. Silverstein, Helen Mabry, et al.. (2005). Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. The American Journal of Surgery. 190(4). 521–525. 77 indexed citations
2.
Klein, Laura, Ye Wei, Dennis R. Holmes, et al.. (2004). Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. The American Journal of Surgery. 188(4). 371–376. 38 indexed citations
3.
Streeter, Oscar E., Frank A. Vicini, Martin Keisch, et al.. (2003). MammoSite® radiation therapy system. The Breast. 12(6). 491–496. 17 indexed citations
4.
Silberman, Howard, et al.. (2002). Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy. The American Journal of Surgery. 184(5). 403–409. 22 indexed citations
5.
Silberman, Howard, Ye Wei, Richard Sposto, et al.. (2002). Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. The American Journal of Surgery. 184(4). 337–340. 71 indexed citations
6.
García, Agustin A., Franco M. Muggia, Colin Paul Spears, et al.. (2001). Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2′-deoxyuridine and leucovorin. Anti-Cancer Drugs. 12(6). 505–511. 4 indexed citations
7.
Metzger, R., Cynthia G. Leichman, Kathleen D. Danenberg, et al.. (1998). ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.. Journal of Clinical Oncology. 16(1). 309–316. 421 indexed citations
8.
Formenti, Silvia C., Gary L. Dunnington, Heinz Josef Lenz, et al.. (1997). Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 39(5). 1059–1068. 47 indexed citations
9.
Skinner, Kristin A., Gary L. Dunnington, Howard Silberman, et al.. (1997). Preoperative 5-fluorouracil and radiation therapy for locally advanced breast cancer. The American Journal of Surgery. 174(6). 705–708. 27 indexed citations
10.
Lenz, Heinz-Josef, Cynthia G. Leichman, Kathleen D. Danenberg, et al.. (1996). Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.. Journal of Clinical Oncology. 14(1). 176–182. 301 indexed citations
11.
Leichman, Lawrence, Heinz‐Josef Lenz, Cynthia G. Leichman, et al.. (1995). Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial. European Journal of Cancer. 31(7-8). 1306–1310. 112 indexed citations
12.
Keung, Yi‐Kong, et al.. (1994). Comparative study of infections complications of different types of chronic central venous access devices. Cancer. 73(11). 2832–2837. 38 indexed citations
13.
Treiman, Gerald S. & Howard Silberman. (1993). Chronic venous access in patients with cancer selective use of the saphenous vein. Cancer. 72(3). 760–765. 10 indexed citations
14.
Leichman, Lawrence, Howard Silberman, Cynthia G. Leichman, et al.. (1992). Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.. Journal of Clinical Oncology. 10(12). 1933–1942. 83 indexed citations
15.
Spicer, Darcy, Bach Ardalan, John R. Daniels, Howard Silberman, & Kay Johnson. (1988). Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics.. PubMed. 48(2). 459–61. 36 indexed citations
16.
17.
Silberman, Howard, et al.. (1980). Leiomyosarcoma of the gastrointestinal tract: Should we consider metastasis to regional lymph nodes?. Journal of Surgical Oncology. 15(4). 319–321. 15 indexed citations
18.
Silberman, Howard, et al.. (1979). Pneumococcal vaccination in recipients of renal allografts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30. 156–7. 5 indexed citations
19.
Silberman, Howard, et al.. (1978). B-cell antibodies in patients with rejecting transplants.. PubMed. 10(3). 603–4. 1 indexed citations
20.
Tornyos, Karl, Howard Silberman, & Alan Solomon. (1977). Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.. PubMed. 61(5). 785–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Crucitti Breakdown of academic impact, for papers by Jan‐Sing Hsieh Breakdown of academic impact, for papers by Tomoo Tajima Breakdown of academic impact, for papers by Carmine Pinto Breakdown of academic impact, for papers by Jyrki Mäkelä Breakdown of academic impact, for papers by Narihide Goseki Breakdown of academic impact, for papers by Şuayib Yalçın Breakdown of academic impact, for papers by Takashi Matsumata Breakdown of academic impact, for papers by Pierre H. Chapuis Breakdown of academic impact, for papers by Jy‐Ming Chiang
Rankless by CCL
2026